Page last updated: 2024-10-26

dipyridamole and Reticulum Cell-Like Sarcoma, Yoshida

dipyridamole has been researched along with Reticulum Cell-Like Sarcoma, Yoshida in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strom, R1
Santoro, AS1
Crifo', C1
Bozzi, A1
Mondovi', B1
Fanelli, AR1
Schmähl, D1
Höllenriegel, K1
Mundt, D1

Other Studies

2 other studies available for dipyridamole and Reticulum Cell-Like Sarcoma, Yoshida

ArticleYear
The biochemical mechanism of selective heat sensitivity of cancer cells. IV. Inhibition of RNA synthesis.
    European journal of cancer, 1973, Volume: 9, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Carcinoma, Ehrlich Tumor; Cell Membrane Permeability; Dipyridamole;

1973
[Investigations in multi-step-therapy of cancer (according to M. v. Ardenne) in animal experiments (author's transl)].
    Archiv fur Geschwulstforschung, 1974, Volume: 43, Issue:3

    Topics: Animals; Ascorbic Acid; Benzopyrenes; Carcinoma; Carcinoma, Ehrlich Tumor; Dipyridamole; Female; Glu

1974